Early Access — free while we kick the tires
EdgarHawk

Fred S Zeidman

Director

Director

Latest: Director buying · March 2026

1 filing analyzed · 1 company · Latest 2026-05-18

Never miss a filing from Fred S Zeidman

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Bluejay Diagnostics, Inc. BJDX 1 0 Net buying

Activity

May 2026
low
Buy
12,500 shares
$25,000
Significance 3/10

Director Fred S Zeidman purchases 12,500 shares of BJDX at $2.00 via private placement; stock down -89.7% from 52-week high.

Director Fred S Zeidman acquired 12,500 shares at $2.00 on 2026-03-14 through a private placement structure, meaning this transaction is not a discretionary open-market purchase. The stock has deteriorated significantly, currently trading at $1.72, down -89.7% from its 52-week high of $16.68, and down -36.1% over the past 90 days. The company's fundamentals remain stressed: latest quarterly revenue was $249.0K while net income was $-1.9M, with the company unprofitable over its most recent full fiscal year. The combination of structured equity allocation, severe stock decline, and ongoing losses suggests this was likely part of a financing event rather than a reflection of near-term business trajectory.

Related insiders